Abstract
Despite the long history of drug discovery from natural sources, the marine environment, which covers 70% of the Earths surface, is still relatively unexplored. Intense competition for limited resources drives the evolution of specific and potent chemical defenses distinct from their terrestrial counterparts. Based on this rationale, we recently began screening extracts derived from marine invertebrate and cyanobacterial samples for BACE-1 inhibitors in a chemiluminescent enzyme-fragment complementation (EFC) assay. The results of this broad screening are presented here, along with our progress towards the development of a secondary LC-MS homogeneous affinity assay. Incubation of the extracts active in the EFC assay with BACE1, subsequent isolation of the enzyme-inhibitor complex and then analysis of the small molecule inhibitor by LC-MS rapidly links a chemical structure to biological activity. This approach enables the rapid targetorientated discovery of BACE-1 inhibitors from marine sources.
Keywords: Marine natural products, BACE, drug discovery
Current Alzheimer Research
Title: New Methods to Explore Marine Resources for Alzheimers Therapeutics
Volume: 7 Issue: 3
Author(s): P. Williams, A. Sorribas and Z. Liang
Affiliation:
Keywords: Marine natural products, BACE, drug discovery
Abstract: Despite the long history of drug discovery from natural sources, the marine environment, which covers 70% of the Earths surface, is still relatively unexplored. Intense competition for limited resources drives the evolution of specific and potent chemical defenses distinct from their terrestrial counterparts. Based on this rationale, we recently began screening extracts derived from marine invertebrate and cyanobacterial samples for BACE-1 inhibitors in a chemiluminescent enzyme-fragment complementation (EFC) assay. The results of this broad screening are presented here, along with our progress towards the development of a secondary LC-MS homogeneous affinity assay. Incubation of the extracts active in the EFC assay with BACE1, subsequent isolation of the enzyme-inhibitor complex and then analysis of the small molecule inhibitor by LC-MS rapidly links a chemical structure to biological activity. This approach enables the rapid targetorientated discovery of BACE-1 inhibitors from marine sources.
Export Options
About this article
Cite this article as:
Williams P., Sorribas A. and Liang Z., New Methods to Explore Marine Resources for Alzheimers Therapeutics, Current Alzheimer Research 2010; 7 (3) . https://dx.doi.org/10.2174/156720510791050812
DOI https://dx.doi.org/10.2174/156720510791050812 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aptamers Against Cell Surface Receptors: Selection, Modification and Application
Current Medicinal Chemistry Innovations and Improvements in Pharmacokinetic Models Based on Physiology
Current Drug Delivery LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Current Pharmaceutical Design Treatment for Cancer Patients with Oral Mucositis: Assessment Based on the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer in International Society of Oral Oncology (MASCC/ISOO) in 2013 and Proposal of Possible Novel Treatment with a Japanese Herbal Medicine
Current Pharmaceutical Design Tool Developments for Structure-Function Studies of Host Defense Peptides
Protein & Peptide Letters Differential Gene Expression of <i>ASUN, NEMF, PTPRC</i> and <i>DHX29</i>: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis
Infectious Disorders - Drug Targets Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers
Current Pharmaceutical Biotechnology A Review of Pharmacokinetic Parameters of Metabolites and Prodrugs
Drug Metabolism Letters Recent Patents on Biomedical Applications for the Treatment of Atherosclerosis
Recent Patents on Regenerative Medicine Isolation, Characterization and Preliminary Cytotoxic and Antifungal Evaluations of Novel Lancifoliate Isolated from Methanol Extract of <i>Conocarpus lancifolius</i>
Anti-Cancer Agents in Medicinal Chemistry Oyster Mushroom Laccase Inhibits Hepatitis C Virus Entry into Peripheral Blood Cells and Hepatoma Cells
Protein & Peptide Letters Designing and In-Vitro Characterization of Micelle Forming Amphiphilic PEGylated Rapamycin Nanocarriers for the Treatment of Gastric Cancer
Current Drug Delivery Vitamin D and the Metabolic Syndrome
Current Vascular Pharmacology Potential of Nanocarriers in Genetic Immunization
Recent Patents on Drug Delivery & Formulation The Misuse of Prescription Opioids: A Threat for Europe?
Current Drug Abuse Reviews Amelioration of Cisplatin Induced Nephrotoxicity by Standardized Methanolic Extract of Roots of Boerhaavia diffusa
The Natural Products Journal In vitro Antimicrobial Activity of Liposomes Containing Ciprofloxacin,Meropenem and Gentamicin Against Gram-Negative Clinical Bacterial Strains
Letters in Drug Design & Discovery Natural Product Photoantimicrobials
Current Bioactive Compounds Dinuclear Berenil-Platinum (II) Complexes as Modulators of Apoptosis in Human MCF-7 and MDA-MB231 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Animal Venom Peptides: Potential for New Antimicrobial Agents
Current Topics in Medicinal Chemistry